These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16787330)

  • 1. Statin attenuates high glucose-induced and angiotensin II-induced MAP kinase activity through inhibition of NAD(P)H oxidase activity in cultured mesangial cells.
    Yu HY; Inoguchi T; Nakayama M; Tsubouchi H; Sato N; Sonoda N; Sasaki S; Kobayashi K; Nawata H
    Med Chem; 2005 Sep; 1(5):461-6. PubMed ID: 16787330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement.
    Tsubouchi H; Inoguchi T; Sonta T; Sato N; Sekiguchi N; Kobayashi K; Sumimoto H; Utsumi H; Nawata H
    Free Radic Biol Med; 2005 Aug; 39(4):444-52. PubMed ID: 16043016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells.
    Inoguchi T; Li P; Umeda F; Yu HY; Kakimoto M; Imamura M; Aoki T; Etoh T; Hashimoto T; Naruse M; Sano H; Utsumi H; Nawata H
    Diabetes; 2000 Nov; 49(11):1939-45. PubMed ID: 11078463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
    Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
    Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species.
    Xie Z; Pimental DR; Lohan S; Vasertriger A; Pligavko C; Colucci WS; Singh K
    J Cell Physiol; 2001 Jul; 188(1):132-8. PubMed ID: 11382929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
    Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells.
    Laplante MA; Wu R; El Midaoui A; de Champlain J
    J Hypertens; 2003 May; 21(5):927-36. PubMed ID: 12714867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II.
    Yatabe J; Sanada H; Yatabe MS; Hashimoto S; Yoneda M; Felder RA; Jose PA; Watanabe T
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1052-60. PubMed ID: 19261744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol.
    Zhang L; Pang S; Deng B; Qian L; Chen J; Zou J; Zheng J; Yang L; Zhang C; Chen X; Liu Z; Le Y
    Int J Biochem Cell Biol; 2012 Apr; 44(4):629-38. PubMed ID: 22245600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells.
    Gorin Y; Ricono JM; Wagner B; Kim NH; Bhandari B; Choudhury GG; Abboud HE
    Biochem J; 2004 Jul; 381(Pt 1):231-9. PubMed ID: 15027896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice.
    Moon JY; Tanimoto M; Gohda T; Hagiwara S; Yamazaki T; Ohara I; Murakoshi M; Aoki T; Ishikawa Y; Lee SH; Jeong KH; Lee TW; Ihm CG; Lim SJ; Tomino Y
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1271-82. PubMed ID: 21367916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
    Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
    J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
    Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II stimulates MCP-1 production in rat glomerular endothelial cells via NAD(P)H oxidase-dependent nuclear factor-kappa B signaling.
    Pan Q; Yang XH; Cheng YX
    Braz J Med Biol Res; 2009 Jun; 42(6):531-6. PubMed ID: 19448902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone.
    Chen J; Mehta JL
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1738-45. PubMed ID: 16714359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB.
    Block K; Ricono JM; Lee DY; Bhandari B; Choudhury GG; Abboud HE; Gorin Y
    Antioxid Redox Signal; 2006; 8(9-10):1497-508. PubMed ID: 16987006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor.
    Takayama T; Wada A; Tsutamoto T; Ohnishi M; Fujii M; Isono T; Horie M
    Circ J; 2004 Nov; 68(11):1067-75. PubMed ID: 15502390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease.
    Rueckschloss U; Quinn MT; Holtz J; Morawietz H
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1845-51. PubMed ID: 12426214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes.
    Graham S; Gorin Y; Abboud HE; Ding M; Lee DY; Shi H; Ding Y; Ma R
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C304-15. PubMed ID: 21525431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NADPH oxidase-derived reactive oxygen species involved in angiotensin II-induced monocyte chemoattractant protein-1 expression in mesangial cells].
    Chen Y; Zhang AH; Huang SM; Ding GX; Zhang WZ; Bao HY; Wu HM; Chen RH
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):456-61. PubMed ID: 19781192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.